Disrupting the transmembrane domain interface between PMP22 and MPZ causes peripheral neuropathy.

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Peripheral myelin proteins Peripheral myelin protein 22 (PMP22) and Myelin protein zero (MPZ) are vital for Schwann cell function.
• Alterations in PMP22 and MPZ cause demyelinating peripheral neuropathies like Charcot-Marie-Tooth (CMT).
• The precise molecular functions of PMP22 and the mechanisms by which its mutations lead to CMT remain unclear.

Purpose of the Study:

• To elucidate the molecular interactions between PMP22 and MPZ.
• To investigate the functional consequences of the PMP22 A67T variant on the PMP22-MPZ complex.
• To define the structural basis of the PMP22-MPZ interaction and its role in myelin.

Main Methods:

• Co-immunoprecipitation assays to detect protein complex formation.
• Analysis of protein localization using cell-based models.
• Characterization of patient-derived variants in protein-protein interactions.

Main Results:

• MPZ and PMP22 form a specific complex mediated by their transmembrane domains.
• The PMP22 A67T variant, associated with Hereditary Neuropathy with Pressure Palsies, disrupts MPZ binding.
• This disruption occurs without affecting PMP22's localization or interactions with other proteins.

Conclusions:

• The MPZ-PMP22 complex is structurally defined by transmembrane domain interactions.
• The PMP22 A67T variant's loss-of-function phenotype arises from impaired MPZ association.
• This interaction is critical for myelin function in Schwann cells, and its disruption underlies specific peripheral neuropathies.